Displaying drugs 14201 - 14225 of 14642 in total
NX-210c
Investigational
Gresonitamab
Investigational
Vepsitamab
Investigational
Ifinatamab deruxtecan
Investigational
Haptoglobulin 1/1 (Plasma Derived)
Investigational
KB407
Investigational
Belcesiran
Investigational
SPK-7001
Investigational
M012
Investigational
Nadunolimab
Investigational
OAV401
Investigational
ET-101
Investigational
MRT5005
MRT5005 is a human cystic fibrosis transmembrane conductance regulator (hCFTR) messenger RNA (mRNA) complexed with branched polyethyleneimine (bPEI).
Investigational
C134
C134 is a genetically engineered oncolytic herpes simplex virus expressing human cytomegalovirus (HCMV) internal repeat short 1 (IRS1).
Investigational
A-16L
Investigational
Ulviprubart
Investigational
BVX-20
Investigational
OBI-888
Investigational
4A10
Investigational
SEA-BCMA
Investigational
M002
Investigational
NCATS-BL0746
Investigational
ADVM-062
ADVM-062 is an adeno-associated virus vector carrying complementary deoxyribonucleic acid encoding the human long-wave-sensitive opsin 1 (AAV.7m8-L-opsin)
Investigational
AMG-553
AMG-553 is an adoptive, anti-FLT3 chimeric antigen receptor T-cell therapy generated through transduction of autologous T-cells with a self-inactivating human immunodeficiency virus-1 based lentiviral vector.
Investigational
Displaying drugs 14201 - 14225 of 14642 in total